Key result
Fitbit-Flex was correlated with Actigraph for step counts but over-estimated steps by 1038 per day and MVPA by 10 minutes per day.
Why the study?
Does the Fitbit-Flex accurately measure daily step counts and MVPA compared to the Actigraph accelerometer in a cardiac rehabilitation population?
Observational (n=48)
Does the Fitbit-Flex accurately measure daily step counts and MVPA compared to the Actigraph accelerometer in a cardiac rehabilitation population?
Fitbit-Flex is a valid tool for assessing attainment of physical activity guidelines in cardiac rehabilitation patients, despite slight overestimation of steps and MVPA.
Answers are grounded in this paper and cite their sources.
Overestimation by Fitbit-Flex warrants caution for precise activity tracking in cardiac rehab; leaves open need for device calibration studies.
BACKGROUND: Accurate physical activity monitoring is important for cardiac patients. Novel activity monitoring devices may enable precise measurement of physical activity. This study aimed to validate Fitbit-Flex against Actigraph accelerometer for monitoring physical activity. DESIGN: A validation study with a comparative design. METHODS: Cardiac patients and family members participating in community-based exercise programs wore Fitbit-Flex and Actigraph simultaneously over four days to monitor daily step counts and minutes of moderate to vigorous physical activity (MVPA). RESULTS: Participants (N = 48) comprised 52.1% males, with a mean age of 65.6 ± 6.9 years and 58.9% had a cardiac diagnosis. Fitbit-Flex and Actigraph were significantly correlated in males, females, total participants and cardiac patients for step counts (r = .96; r = .95; r = .95; r = .95), though less so for MVPA (r = .81; r = .65, r = .74; r = .71). As step counts increased the differences between Fitbit-Flex and Actigraph also increased. Fitbit-Flex over-estimated step counts in females (556 steps/day), males (1462 steps/day) and total participants (1038 steps/day) as well as for minutes of MVPA in females (4 min/day), males (15 min/day) and total participants (10 min/day). Fitbit-Flex had high sensitivity and specificity in classifying participants who achieved the recommended physical activity guidelines. CONCLUSION: Fitbit-Flex is accurate in assessing attainment of physical activity guideline recommendations and is useful for monitoring physical activity in cardiac patients. The device does, however, slightly over-estimate step counts and MVPA.
No takes yet. Share an insight, caveat, or question.
Alharbi et al. (2016) conducted an observational in Cardiac rehabilitation (n=48). Fitbit-Flex vs. Actigraph accelerometer was evaluated on Daily step counts and minutes of moderate to vigorous physical activity (MVPA) (r = 0.95 for step counts; r = 0.74 for MVPA). Fitbit-Flex was correlated with Actigraph for step counts but over-estimated steps by 1038 per day and MVPA by 10 minutes per day.
Synapse has enriched 10 related papers. Consider them for comparative context: